ASAS40

Advertisement

cGxPJobs Banner

Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA

MILAN, Italy — September 18, 2026 Alfasigma announced that the Committee for Medicinal Products for Human Use (CHMP) of...

By cGxPwire Editor
September 23, 2026

Read More

Lynk Pharmaceuticals Completes Phase III AS Trial Enrollment

HANGZHOU, China, SHANGHAI & BOSTON — July 14, 2026 Lynk Pharmaceuticals Co., Ltd. has announced the successful completion of...

By cGxPwire Editor
July 16, 2026

Read More

Advertisement

cGxPJobs

Directory